Biotron (ASX:BIT) has announced the acquisition of Sedarex, the owner of global patents for SedRx, a next-generation general anaesthetic with the potential to reshape the $6.5 billion global anaesthesia market. The deal is backed by a $2.5 million capital raising through a placement and rights offer, led by Peak Asset Management. …
Biotron to acquire Sedarex and raise $2.5 million to accelerate anaesthetic program
October 15, 2025 Australian Biotech
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - Series 5. Ep.30
August 28, 2026 - - Podcast -
Sandoz earns workplace recognition amid push for medicine access
August 28, 2026 - - Latest News -
Cheaper medicines save Australians $1.4 billion as pharmacists urge freeze for all patients
August 28, 2026 - - Latest News -
Mayne Pharma bets on women’s health and direct distribution after a difficult year
August 28, 2026 - - Latest News -
Patients Australia puts healthcare’s quiet achievers in the spotlight
August 28, 2026 - - Latest News -
Weight loss medicines drive revenue growth for Sigma and Wesfarmers Health
August 28, 2026 - - BioPharma -
Cathy Freeman to headline 2026 Patient’s Choice Awards
August 27, 2026 - - Latest News